SHARE Talk Radio Presents: EMBRCA Trial

Dr. Denise Yardley, Senior Investigator of Breast Cancer Research at Sarah Cannon Research Institute, and 
Medical Oncologist with Tennessee Oncology, PLLC, will present and answer questions about this phase 3 clinical trial for women with BRCA 1 or 2 positive metastatic breast cancer. Phase 1 and 2 trials of this drug reported promising results: 10 out of 12 women benefited from this experimental drug. The EMBRCA trial is available at 53 sites worldwide. This program supports the work of the National Breast Cancer Coalition (NBCC) to educate the public about the EMBRCA trial.